HF
FOLD

HRT Financial’s Amicus Therapeutics FOLD Stock Holding History

HRT Financial’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-161,918
Closed -$927K – 3110
2025
Q2 		$927K Sell
161,918
-103,776
-39% -$670K ﹤0.01% 1299
2025
Q1 		$2.17M Buy
265,694
+163,304
+159% +$1.51M 0.01% 781
2024
Q4 		$964K Buy
102,390
+51,589
+102% +$536K 0.01% 1099
2024
Q3 		$542K Buy
+50,801
New +$553K ﹤0.01% 1552
2023
Q2 		– Sell
-204,695
Closed -$2.27M – 2719
2023
Q1 		$2.27M Sell
204,695
-85,981
-30% -$1.06M 0.03% 534
2022
Q4 		$3.55M Buy
290,676
+238,531
+457% +$2.69M 0.05% 368
2022
Q3 		$544K Buy
+52,145
New +$581K 0.01% 1380
2021
Q4 		– Sell
-161,594
Closed -$1.54M – 3468
2021
Q3 		$1.54M Buy
+161,594
New +$1.65M 0.01% 908
2020
Q4 		– Sell
-97,800
Closed -$1.38M – 2052
2020
Q3 		$1.38M Buy
+97,800
New +$1.43M 0.04% 376
2019
Q4 		– Sell
-23,671
Closed -$189K – 1318
2019
Q3 		$189K Buy
+23,671
New +$257K 0.01% 1168

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

HRT Financial's FOLD Position: Q3 2025 in Review

HRT Financial sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 161,918 shares — an estimated $927K sold.

HRT Financial first reported a position in FOLD in Q3 2019 and held it in 10 quarters. The position peaked at $3.55M in Q4 2022. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • HRT Financial reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 161,918 Amicus Therapeutics shares in Q3 2025, an estimated $927K.
  • HRT Financial first reported a position in Amicus Therapeutics in Q3 2019 and held it in 10 quarters.
  • HRT Financial's Amicus Therapeutics position peaked at $3.55M in Q4 2022.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.